Literatur
-
1
Koop H, Schepp W, Muller-Lissner S. et al .
Consensus conference of the DGVS on gastroesophageal reflux.
Z Gastroenterol.
2005;
43
163-164
-
2
Schepp W, Allescher H D, Frieling T. et al .
Topic complex I: Definitions, epidemiology and natural course.
Z Gastroenterol.
2005;
43
165-168
-
3
Koop H, Classen M, Liebe S, Lutke A, Wienbeck M.
Therapy of non-erosive reflux disease (NERD).
Z Gastroenterol.
2005;
43
176-179
-
4
Laine L, Ahnen D, McClain C, Solcia E, Walsh J H.
Review article: potential gastrointestinal effects of long-term acid suppression with proton pump inhibitors.
Aliment Pharmacol Ther.
2000;
14
651-668
-
5
Messmann H, Ell C, Fein M. et al .
Complex VI: Barrett esophagus.
Z Gastroenterol.
2005;
43
184-190
-
6
Behrens A, May A, Gossner L. et al .
Curative treatment for high-grade intraepithelial neoplasia in Barrett’s esophagus.
Endoscopy.
2005;
37
999-1005
-
7
Li Y, Wo J M, Ray M B. et al .
Cyclooxygenase-2 and epithelial growth factor receptor up-regulation during progression of Barrett’s esophagus to adenocarcinoma.
Gastroenterol.
2006;
12
928-934
-
8
Morgner-Miehlke A, Koop H, Blum A L. et al .
Symptom- versus Endoscopy-Based Diagnosis and Treatment of Gastroesophageal Reflux Disease (GERD).
Z Gastroenterol.
2006;
44
399-410
-
9
Leontiadis G I, Sharma V K, Howden C W.
Proton pump inhibitor treatment for acute peptic ulcer bleeding.
Cochrane Database Syst Rev.
2006;
1
-
10
Vergara M, Catalan M, Gisbert J P, Calvet X.
Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users.
Aliment Pharmacol Ther.
2005;
21
1411-1418
-
11
Chong G, Cunningham D.
Gastrointestinal cancer: recent developments in medical oncology.
Eur J Surg Oncol.
2005;
31
453-460
-
12
Macdonald J S, Smalley S R, Benedetti J. et al .
Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction.
N Engl J Med.
2001;
345
725-730
-
13
Kwon R S, Brugge W R.
New advances in pancreatic imaging.
Curr Opin Gastroenterol.
2005;
21
561-567
-
14
Meier R, Ockenga J, Pertkiewicz M. et al .
ESPEN Guidelines on Enteral Nutrition: Pancreas.
Clin Nutr.
2006;
Epub ahead of print
-
15
Moyshenyat I, Mandell E, Tenner S.
Antibiotic prophylaxis of pancreatic infection in patients with necrotizing pancreatitis: rationale, evidence, and recommendations.
Curr Gastroenterol Rep.
2006;
8
121-126
-
16
Lankisch P G, Lerch M M.
The role of antibiotic prophylaxis in the treatment of acute pancreatitis.
J Clin Gastroenterol.
2006;
40
149-155
-
17
Penner R, Fedorak R N, Madsen K L.
Probiotics and nutraceuticals: non-medicinal treatments of gastrointestinal diseases.
Curr Opin Pharmacol.
2005;
5
596-603
-
18
Maisonneuve P, Lowenfels A B, Mullhaupt B. et al .
Cigarette smoking accelerates progression of alcoholic chronic pancreatitis.
Gut.
2005;
54
510-514
-
19
Chari S T, Leibson C L, Rabe K G. et al .
Probability of pancreatic cancer following diabetes: a population-based study.
Gastroenterology.
2005;
129
504-511
-
20
Moore M J.
Brief communication: a new combination in the treatment of advanced pancreatic cancer.
Semin Oncol.
2005;
(6 Suppl 8)
32
5-6
-
21
Lau G K, Piratvisuth T, Luo K X. et al .
Peginterferon Alfa-2a, lamivudine, and the combination for HBeAg-positive chronic hepatitis B.
N Engl J Med.
2005;
352
2682-2695
-
22
Chan H L, Hui A Y, Wong V W. et al .
Long-term follow-up of peginterferon and lamivudine combination treatment in HBeAg-positive chronic hepatitis B.
Hepatology.
2005;
41
1357-1364
-
23
Mangia A, Santoro R, Minerva N. et al .
Peginterferon alfa-2b and ribavirin for 12 vs. 24 weeks in HCV genotype 2 or 3.
N Engl J Med.
2005;
352
2609-2617
-
24
Berg T, von Wagner M, Nasser S. et al .
Extended treatment duration for hepatitis C virus type 1: comparing 48 versus 72 weeks of peginterferon-alfa-2a plus ribavirin.
Gastroenterology.
2006;
130
1086-1097
-
25
Schilsky M L, Fink S.
Inherited metabolic liver disease.
Curr Opin Gastroenterol.
2006;
22
215-222
-
26
Marrero J A.
Hepatocellular carcinoma.
Curr Opin Gastroenterol.
2006;
22
248-253
-
27
Farrell G C, Larter C Z.
Nonalcoholic fatty liver disease: from steatosis to cirrhosis.
Hepatology.
2006;
43
S99-S112
-
28
Eliakim A R.
Video capsule endoscopy of the small bowel (PillCam SB).
Curr Opin Gastroenterol.
2006;
22
124-127
-
29
Golder S K, Schreyer A G, Endlicher E. et al .
Comparison of capsule endoscopy and magnetic resonance (MR) enteroclysis in suspected small bowel disease.
Int J Colorectal Dis.
2006;
21
97-104
-
30
Yamamoto H, Kita H.
Double-balloon endoscopy: from concept to reality.
Gastrointest Endosc Clin N Am.
2006;
16
347-361
-
31
Heine G D, Hadithi M, Groenen M J. et al .
Double-balloon enteroscopy: indications, diagnostic yield, and complications in a series of 275 patients with suspected small-bowel disease.
Endoscopy.
2006;
38
42-48
-
32
Ell C, May A, Nachbar L. et al .
Push-and-pull enteroscopy in the small bowel using the double-balloon technique: results of a prospective European multicenter study.
Endoscopy.
2005;
37
613-616
-
33
Spiller R, Campbell E.
Post-infectious irritable bowel syndrome.
Curr Opin Gastroenterol.
2006;
22
13-21
-
34
Eckmann L.
Innate immunity and mucosal bacterial interactions in the intestine.
Curr Opin Gastroenterol.
2004;
20
82-88
-
35
Hanauer S B.
Inflammatory bowel disease: epidemiology, pathogenesis, and therapeutic opportunities.
Inflamm Bowel Dis.
2006;
12
S3-9
-
36
Kruis W, Fric P, Pokrotnieks J. et al .
Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.
Gut.
2004;
53
1617-1616
-
37
Jarnerot G, Hertervig E, Friis-Liby I. et al .
Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.
Gastroenterology.
2005;
128
1805-1811
-
38
Rutgeerts P, Sandborn W J, Feagan B G. et al .
Infliximab for induction and maintenance therapy for ulcerative colitis.
N Engl J Med.
2005;
353
2462-2426
-
39
Mulhall B P, Veerappan G R, Jackson J L.
Meta-analysis: computed tomographic colonography.
Ann Intern Med.
2005;
142
635-650
-
40
Hartmann D, Bassler B, Schilling D. et al .
Colorectal polyps: detection with dark-lumen MR colonography versus conventional colonoscopy.
Radiology.
2006;
238
143-149
-
41
Kiesslich R, Hoffman A, Neurath M F.
Colonoscopy, tumors, and inflammatory bowel disease - new diagnostic methods.
Endoscopy.
2006;
38
5-10
-
42
Dekker E, Fockens P.
Advances in colonic imaging: new endoscopic imaging methods.
Eur J Gastroenterol Hepatol.
2005;
17
803-808
-
43
Kiesslich R, Gotz M, Neurath M F, Galle P R.
Endomicroscopy-technology with future.
Internist.
2006;
47
8-17
-
44
Vucelic B, Rex D, Pulanic R. et al .
The aer-o-scope: proof of concept of a pneumatic, skill-independent, self-propelling, self-navigating colonoscope.
Gastroenterology.
2006;
130
672-677
Dr. med. Axel Eickhoff
Prof. Dr. med. Jürgen F. Riemann
Medizinische Klinik C
Klinikum der Stadt
Ludwigshafen gGmbH
Bremserstraße 79
67063 Ludwigshafen
Telefon: 0621/5034100
Fax: 0621/5034114
eMail: eickhofa@klilu.de
